- 专利标题: NEUROMUSCULAR DISEASE EVALUATION SYSTEM
-
申请号: US18247015申请日: 2021-09-29
-
公开(公告)号: US20230355163A1公开(公告)日: 2023-11-09
- 发明人: Takeshi SAKATA , Akiko GOTO , Atsushi KATO , Manabu HIRAI
- 申请人: MITSUBISHI TANABE PHARMA CORP
- 申请人地址: JP Osaka
- 专利权人: MITSUBISHI TANABE PHARMA CORP
- 当前专利权人: MITSUBISHI TANABE PHARMA CORP
- 当前专利权人地址: JP Osaka
- 优先权: JP 20163596 2020.09.29
- 国际申请: PCT/JP2021/035951 2021.09.29
- 进入国家日期: 2023-03-28
- 主分类号: A61B5/00
- IPC分类号: A61B5/00 ; A61B5/11
摘要:
A neuromuscular disease evaluation device that is less invasive, highly sensitive, quantitative and objective, and capable of easily evaluating neuromuscular diseases. A device for evaluating motor functions related to neuromuscular diseases, comprising: a memory unit storing a reference value for evaluating a predetermined movement, which is calculated based on a position of at least one body part; an analysis unit for identifying a position of a body part of the user by analyzing information based on an image captured of the predetermined movement, including the user's body; and an evaluation unit for evaluating the motor function based on the numerical value calculated based on the position of the body part of the user and the reference value.
信息查询